Dr. Nima Nabavizadeh, MD
Claim this profileOHSU Knight Cancer Institute
Studies Cancer
Studies Liver Cancer
6 reported clinical trials
10 drugs studied
Area of expertise
1Cancer
Stage I
Stage II
2Liver Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Nima Nabavizadeh, MD is currently running
TAS-102 + Radiation
for Rectal Cancer
This phase 1b trial studies the side effects and best dose of TAS-102 when given together with radiation therapy in treating patients with stage II-III rectal cancer that has not been treated and can be removed by surgery (resectable). Drugs used in chemotherapy, such as TAS-102, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out the safest dose of TAS-102 that can be used with radiation treatment for rectal cancer.
Recruiting1 award Phase 122 criteria
Early Detection Test
for Cancer
This trial is testing a new blood test called the GRAIL MCED test, which aims to detect multiple types of cancer early. GRAIL, a company formed by DNA-sequencing giant Illumina, is developing the GRAIL MCED test to detect multiple cancer types early. It targets people who are already recommended for cancer screening. The test works by looking for cancer-related DNA in the blood, and if found, further tests are done to confirm and locate the cancer.
Recruiting1 award N/A2 criteria
More about Nima Nabavizadeh, MD
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Nima Nabavizadeh, MD has experience with
- Stereotactic Body Radiation Therapy
- Intensity-Modulated Radiation Therapy
- Multi-Cancer Early Detection Test
- Genome-wide Methylome Enrichment Platform
- Trifluridine And Tipiracil Hydrochloride
- 3-Dimensional Conformal Radiation Therapy
Breakdown of trials Nima Nabavizadeh, MD has run
Cancer
Liver Cancer
Hepatocellular Carcinoma
Early Detection of Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nima Nabavizadeh, MD specialize in?
Nima Nabavizadeh, MD focuses on Cancer and Liver Cancer. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage II.
Is Nima Nabavizadeh, MD currently recruiting for clinical trials?
Yes, Nima Nabavizadeh, MD is currently recruiting for 3 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Nima Nabavizadeh, MD has studied deeply?
Yes, Nima Nabavizadeh, MD has studied treatments such as Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, Multi-Cancer Early Detection Test.
What is the best way to schedule an appointment with Nima Nabavizadeh, MD?
Apply for one of the trials that Nima Nabavizadeh, MD is conducting.
What is the office address of Nima Nabavizadeh, MD?
The office of Nima Nabavizadeh, MD is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.